Respected veterinary cardiologist first recipient of Mark

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Respected veterinary cardiologist first recipient of Mark L. Morris Jr. Investigator Award

DENVER, Jan. 12, 2016 (GLOBE NEWSWIRE) -- Morris Animal Foundation has selected Kathryn M. Meurs, DVM, PhD, from North Carolina State University, as the first recipient of the Mark L. Morris Jr. Investigator Award. The award focuses on canine mitral valve disease, the most common cause of heart disease in the dog. Meurs is a leader in the field of genetics of cardiac disease in companion animals, with a proven track record of successfully identifying the genetic basis for numerous canine and feline cardiac diseases. "Mitral valve degeneration is known to be an inherited disease, particularly in certain breeds, although the causative mutations have not been identified," said Barbara Wolfe, DVM, PhD, chief scientific officer at Morris Animal Foundation. "Because we don't fully understand the etiology of the disease, veterinarians primarily treat dogs to alleviate the symptoms. Through this award, we hope to help identify the causes of mitral valve degeneration, so that we can better treat and prevent canine heart disease." With support from the investigator award, Meurs' research team hopes to identify genetic variants that lead to the development of mitral valve degeneration, and use that information to innovate treatment and prevention plans for dogs with high-risk DNA variants. "I firmly believe that once you really understand a disease etiology, you can most effectively develop treatments for the primary disease, and gradually remove or at least reduce the disease prevalence in the population," said Meurs, who is associate dean for research and graduate programs at NCSU's College of Veterinary Medicine. Meurs received her Doctor of Veterinary Medicine from the University of Wisconsin-Madison, completed a small animal rotating internship at North Carolina State, and a cardiology residency at Texas A &M University where she also completed her PhD work in clinical genetics. Her work has led to the identification of genetic mutations for heart disease in companion animals; and development of clinical management recommendations, including for feline cardiomyopathy in Maine coon and ragdoll cats, boxer dog cardiomyopathy and, most recently, long QT syndrome in English springer spaniels. "At North Carolina State, we are incredibly proud and grateful for our relationship with Morris Animal Foundation, and for all that the Morris family has done to support research for animal health," said Meurs. "We are thrilled to have this award coming to NCSU." A veterinary scientist, Mark L. Morris Jr., DVM, PhD, was renowned for his pioneering work in small and exotic animal nutrition, and his tireless dedication to Morris Animal Foundation's mission to advance animal health through excellent science. The Mark L. Morris Jr. Investigator Award, newly established in 2015, honors his legacy and vision. "I think that Mark would be both pleased and honored that Dr. Meurs will be the first recipient of this award," said Dr. Bette Morris, Morris Animal Foundation board trustee, and wife of the late Dr. Morris Jr. "Mark would recognize the importance of understanding the etiology of heart disease as a first step toward preventing the occurrence of the disease and improving treatment." About Morris Animal Foundation Morris Animal Foundation is a global leader in funding science that advances the health and well-being of companion animals, horses and wildlife. Since our founding in 1948, we have invested more than $100 million toward 2,400 studies that have led to significant breakthroughs in diagnostics, treatments, preventions and cures to benefit animals worldwide.

Photos accompanying this release are available at: http://www.globenewswire.com/newsroom/prs/?pkgid=38429 http://www.globenewswire.com/newsroom/prs/?pkgid=38430

Morris Animal Foundation Carol Borchert 303.708.3418 North Carolina State University April Norris 919-513-6423

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 219

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 156

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 160

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading

Top 5 Most Recently Viewed Articles

R Systems Shines as a Major Contender in Engineering Services

Updated Category News Views 206

R Systems Acknowledged for Engineering Excellence R Systems International Limited, a leader in digital product engineering and technology solutions, has been recognized in the latest evaluation conducted by Everest Group. This prominent acknowledgment positions R Systems as a Major Contender in the ISV and Internet-specific SPES PEAK Matrix® Assessment for the year 2024....

Continue Reading
AppFolio Achieves Growth: Analysts Reaffirm $300 Target

Updated Category News Views 68

DA Davidson Affirms $300 Price Target for AppFolio Recently, DA Davidson reaffirmed its Buy rating for AppFolio (NASDAQ: APPF) and maintained a price target of $300. As a leading provider of cloud-based software solutions, AppFolio is recognized for its strategic growth initiatives. The firm highlighted the company's momentum ahead of its third-quarter earnings report and...

Continue Reading
Important Class Action Emerging for West Pharmaceutical Services Investors

Updated Category News Views 162

Class Action Overview for West Pharmaceutical Services, Inc. Levi & Korsinsky, LLP informs all investors in West Pharmaceutical Services, Inc. about a significant class action securities lawsuit arising from claims of securities fraud against the company. This announcement serves as an important notice to those who hold shares of West Pharmaceutical Services, Inc. (NYSE:...

Continue Reading
Zelluna's Upcoming Forum: Insight into Cancer Treatment Strategies

Updated Category News Views 190

Explore the Upcoming Investor Forum by Zelluna Zelluna (OSE: ZLNA), a trailblazer in the realm of allogeneic 'off the shelf' T Cell Receptor-based Natural Killer (TCR-NK) cells aimed at combating cancer, has announced an engaging Investor Science and Strategy Forum that offers a closer look at their innovative approaches. This notable event is set to take place in Oslo,...

Continue Reading
Challenges Facing Airlines Due to Economic Shifts and Strikes

Updated Category News Views 296

Understanding the Shift in Airline Operations As airlines adapt to changing economic conditions and demand patterns, many have begun scaling back their flight offerings to certain international markets. The situation is particularly pronounced with regards to flights to China, where reduced demand and rising operational costs have forced several airlines to reconsider...

Continue Reading